Hepatitis delta virus expresses two forms of a single protein, the small (BAg-S) and large (bAg-L) antigens, which are identical except for an additional 19 residues present at the C terminus of bAg-L. While bAg-S is required to promote genome replication, bAg-L potently inhibits this process and also facilitates packaging of the viral genome by envelope proteins of the helper virus (hepatitis B virus). Regions within the antigens responsible for nuclear localization, RNA binding, and dimerization have been identified, yet it is not clear how these particular activities contribute to the ultimate replication and packaging phenotypes. Here we report the following findings. (i) Although the removal of the nuclear localization signal from either antigen resulted in significant cytoplasmic accumulation, both proteins still had access to the nucleus. As a consequence, no functional defect was observed with either mutant. (ii) The RNA-binding domain, although necessary for bAg-S function, could be deleted from bAg-L without compromising its ability to either inhibit replication or promote packaging. (iii) In contrast, the coiled-coil dimerization domain was required for both the activation of replication by bAg-S and the inhibition of replication by bAg-L. This region, with an additional 20 amino acids C-terminal to it, was necessary and sufficient to potently inhibit replication by interacting with the small antigen. (iv) The packaging property of bAg-L required a C-terminal Pro/Gly-rich region which is hypothesized to interact with the hepatitis B virus envelope proteins during the assembly process.
Hepatitis delta virus (HDV) is a novel human subviral pathogen which is able to infect only persons who were previously or are simultaneously infected with hepatitis B virus (HBV) (27) . The HDV genome is a single-stranded circular RNA of approximately 1.7 kb which is able to fold into an unbranched rod structure, in which 70% of its nucleotides are involved in intramolecular pairing (31) . HDV is fully capable of genome replication in the absence of all helper virus functions; however, the hepadnaviral envelope proteins (s antigens) are necessary to promote the assembly and release of infectious virions (17, 26, 27) . Replication occurs in the nucleus, where a host-encoded, RNA-directed polymerase is thought to synthesize the complement of the genome, termed the antigenome, which then serves as the template for genome synthesis (30) .
HDV encodes a single protein, the 195-amino-acid (a.a.) delta antigen (MAg-S), which functions in the nucleus to promote genome replication (17) . Currently, the mechanism underlying this trans activation is not understood, nor is it known at what stage in the replication cycle the antigen acts. From both in vitro and in vivo studies, however, it is clear that bAg-S binds to the HDV rod-structured RNA to form a ribonucleoprotein (RNP) which is found both within the nucleus and in virions (5, 8, 29) . Although only bAg-S is synthesized early in infection, a second antigen variant, bAg-L, is observed later in infection (1, 31, 32) . This protein is identical to bAg-S except that it has an additional 19 carboxy-terminal residues which result from the mutation of the bAg-S amber codon as a consequence of RNA editing (3, 22, 35) . This editing event is essential for viral propagation because, unlike bAg-S, bAg-L is able to function with the hepadnaviral envelope proteins to direct the packaging of the HDV RNP structure into virions (4, 28) . bAg-L differs phenotypically from bAg-S in a second way; not only is it genomes observed is reduced almost 10-fold (7) . This degree of potency can be explained if a single bAg-L molecule interacts with a multimeric complex, such as the HDV RNP, somehow rendering it incompetent for replication yet competent for packaging.
How does the addition of 19 a.a. to the C terminus of bAg-S result in such drastic phenotypic changes? Part of the answer has recently been discovered by Glenn et al. (13) , who found that the sole cysteine residue of bAg-L (position 211; not present in bAg-S) is isoprenylated. Furthermore, when this residue is mutated to serine to prevent the modification, packaging is abolished. The role of the carboxy-terminal 19 a.a. in inducing trans-dominant inhibition is less clear, however. For instance, an 11-a.a. C-terminal truncation mutant that lacks the isoprenylation site and should not therefore be packaged is still able to inhibit replication, indicating that the two phenotypes of bAg-L may be separable (14) . This possibility has been confirmed by Chen et al., who described a mutant which is competent for packaging but unable to inhibit replication (10) .
There is a growing body of genetic evidence concerning the locations of a number of functional domains within the delta antigen primary sequence (Fig. 1) . A locale encompassing residues 89 to 163 has been shown, in vitro, to direct RNA binding (21) (23) . The role of dimerizatioi phenotypes of bAg-S and bAg-L is unkr least part of the coiled-coil region of bAgto be dispensable for packaging (10 containing EcoRI-BstXI fragment from pDL445, cleaving dues amino-termithis with Sau3A, and then religating the products with the ation (33 (18) , and RNA was isolated by a modification of the acid phenolguanidinium-thiocyanate procedure (12) . Secreted HBV sAg particles were recovered from the medium as described previously (28) . Briefly, 10 ml of medium was clarified by low-speed centrifugation, and the particles were pelleted by high-speed centrifugation (32,000 rpm, 16 h, 4°C) through 2 ml of 20% isotonic sucrose. In vivo cross-linking was done by a modification of the method of Zapp et al. (34) . The medium was supplemented with 0.3% methanol, 10 mM NaCl, 0.1 mM EDTA, and 0.01% glutaraldehyde and added to the cells for 20 min at 37°C, followed by a 3-h incubation at 4°C. Cross-linked cells were washed and then directly lysed and resuspended in sample buffer.
Immunoblot analysis. Protein samples were subjected to electrophoresis on 14% polyacrylamide gels by the method of Laemmli (18) . They were then transferred to nitrocellulose electrophoretically, and delta antigen was detected by using rabbit polyclonal antiserum raised against bacterially expressed antigen and by incubation with '25I-labeled protein A (Du Pont).
RNA analysis. Total cell RNA was separated electrophoretically on 1.5% agarose gels in the presense of ethidium bromide so that both the quality and quantity of RNA in each lane could be monitored. RNA was then electrophoretically transferred to a nylon membrane, and successful transfer was confirmed by visualization with UV light. RNA was UV cross-linked to the membrane and then hybridized with a radiolabeled RNA probe specific for the genomic strand as described previously (11 . In most cases, a given deletion was created in both bAg-L and bAg-S; however, only the bAg-L mutants are diagrammed. The deletion mutation spanning residues 145 to 163 was introduced into both bAg-S and bAg-L, but its effects on the stability of the two proteins were very different. bAg-S(A145-163) was readily detectable, whereas bAg-L(A145-163) was either undetectable or barely detectable, depending on the time posttransfection that it was analyzed. For this reason, no conclusions about the phenotypes of this mutant could be drawn.
All proteins were expressed from SV40 late promoterderived vectors via transient transfection of the human hepatoma cell line Huh7. The mutants were then assayed for relevant phenotypes.
The ability of a protein to localize to the nucleus was assessed by immunofluorescence. Glutaraldehyde crosslinking of intact living cells was used to determine whether a mutant could multimerize in vivo. The ability of each mutant to support genome replication was assayed by cotransfecting a plasmid that transcribes an antigenomic HDV RNA which contains a frameshift mutation in the antigen ORF and requires functional bAg-S in trans in order to replicate. Total cellular RNA was then subjected to Northern (RNA blot) analysis with a probe specific for the product of replication, i.e., HDV genomic RNA. trans-Dominant inhibition of replication was determined in the same manner except that in addition to the HDV RNA and mutant protein-producing constructs, cells were transfected with an equivalent amount of a vector which expresses wild-type bAg-S. A protein's ability to be packaged by the hepadnaviral envelope proteins was determined by cotransfecting a plasmid that produces the HBV sAg. Secreted sAg particles were then isolated and subjected to Western immunoblot analysis with delta antigen-specific antiserum. A summary of the phenotypes of the various mutants is given in Table 1 .
Core nuclear localization signal is dispensable for the function of bAg-S and BAg-L. Both forms of the delta antigen are reported to show three distinct nuclear immunofluorescence staining patterns (33) . With most cells, a punctate nucleolar pattern of localization is observed, in which both the nucleoli and additional subnuclear structures show preferential staining. However, in some cells, both the nucleoplasm and nucleoli are stained, whereas in others, antigen is localized to the nucleoplasm and excluded from the nucleoli. We have also observed these three patterns, and the first and third types can be seen in adjacent cells in Fig. 2A . Currently, we have no explanation for these differences in subnuclear localization, nor do we understand their relevance, if any, to the HDV life cycle. Consistent with earlier findings, we were unable to detect differences in the localization of bAg-S and bAg-L either in the context of the wild-type proteins or with the deletion mutants mentioned below.
It was previously shown that residues 1 to 88 of the delta antigen were sufficient to promote nuclear localization when fused to a cytoplasmic protein (33) . Not (Fig. 2B) (33) .
As would be expected, when the core NLS was removed in bAg-S(A69-74) and bAg-L(A69-74), a significant amount of protein was seen in the cytoplasm ( Fig. 2C and D) . These mutants were not excluded from the nucleus, however, and in fact, some cells showed preferential staining of the nucleoli ( Fig. 2C and D) . (Fig. 3B, lanes a and b) . The presence or absence of bAg-S was confirmed by Western blot analysis (Fig. 3A, lanes a and b) . As shown in Fig. 3B , lane d, bAg-S(A69-74) was fully capable of supporting genome replication with wild-type efficiency. In the trans inhibition assay, the cotransfection of a bAg-L-expressing plasmid with a plasmid expressing bAg-S and HDV RNA abolished replication (compare lanes b and 1 of Fig. 3B ). bAg-L(A69-74) displayed wild-type activity in its ability to inhibit replication (Fig. 3B, lane 3) . Furthermore, in a packaging assay, bAg-L can be secreted into the tissue culture medium if HBV sAg is also expressed, and bAg-L(A69-74) was similarly found to be efficiently packaged into sAg particles (Fig. 4, compare lanes b and B with lanes d and D) .
Coiled-coil region needed for both trans activation of replication by bAg-S and trans inhibition by bAg-L. A program designed to recognize coiled-coil domains in protein primary sequences predicts that the deletion of a.a. 19 to 31 in the delta antigen will abolish the protein's capacity to assume this structure (23) . This deletion was introduced into both bAg-S and bAg-L, and its effect on dimerization was evaluated by two independent methods. When cells which were transiently expressing wild-type bAg-S were subjected to in vivo cross-linking, a significant amount of a product that is consistent in size with a dimer and whose production is dependent on the addition of glutaraldehyde was observed (Fig. 5, lane 4) . The assignment of this novel species as an bAg-S dimer was further substantiated by results obtained with the coiled-coil-containing truncation construct bAg(1-88). Glutaraldehyde-treated cells which expressed this protein did not produce a product of the same size as the bAg-S-expressing cells but rather two smaller products whose sizes are what would be expected for bAg dimers and trimers (Fig. 5, lane 2) . Furthermore, in additional experiments with gels containing a lower percentage of acrylamide, dimers and trimers of both wild-type bAg-S and bAg-L could be resolved (data not shown). These results clearly established that both wild-type proteins as well as bAg(1-88) oligomerized in vivo. However, when cells producing bAg-L(A19-31) were treated in the same manner, only monomeric protein was visualized ( Table 1) .
The inability of bAg-L(A19-31) to oligomerize was also confirmed by packaging experiments. Previously, it was noted that although bAg-S is not packaged into hepadnaviral particles per se, it is copackaged if bAg-L is also present in the cell (28) . This observation was interpreted as indicating a direct protein-protein interaction between bAg-S and bAg-L. Consistent with this notion, when the coiled-coil domain was disrupted in bAg-S(A19-31), the protein was not copackaged by bAg-L (Table 1) . Likewise, although bAg-L(A19-31) did package itself, it was unable to copackage bAg-S (Table 1 ). In addition to providing further evidence that deletion of a.a. 19 to 31 inactivates the coiled coil, this result confirms a previous finding, that the packaging (although not the copackaging) phenotype of bAg-L is independent of dimerization (10) . Disruption of the coiled-coil domain completely inactivated both the trans inhibition and trans activation phenotypes, as bAg-L(A19-31) did not interfere with replication and bAg-S(A19-31) was unable to promote it (Fig. 3B,  lanes 2 and c) .
Inhibition of replication by bAg-L does not require an RNA-binding domain but functions via interaction with BAg-S. To explain the potency of bAg-L in inhibiting replication, we proposed that the protein interacts with and "poisons" the replicating delta virus RNP structure (7) . bAg-L might use its RNA-binding domain to gain access to this RNP. However, a number of our mutants indicated that the region which binds RNA is not needed for inhibition of replication. bAg(1-88), bAg(1-81), bAg-S(A89-145), bAg-L(A89-145), bAg-S(A69-146), bAg-L(A69-146), and bAg-L(A101-202) all potently inhibited replication, although none contain this domain (Table 1 and Fig. 3B, lanes 4 to 7) .
How then do these proteins interact with their target? Since all of the mutants contain the coiled-coil domain, a region which we have just shown is required for inhibition, it seems likely that they could form heterodimers with bAg-S, which in turn would bind HDV RNA. This possibility was verified by in vivo cross-linking. When cells expressing both 5Ag-S and bAg(1-88) were cross-linked, a unique heterodimeric species was observed which was not seen in cells that expressed either protein individually (Fig. 5, compare  lanes 2, 4, and 6 ). Although this heterodimeric species (289 a.a.) is similar in predicted size to and nearly comigrated with the 8Ag(1-88) trimer (282 a.a.), it could be discerned by its relative abundance. While the bAg(1-88) trimer was far less abundant than the dimer, the 8Ag(1-88)/8Ag-S heterodimer was in excess of either homodimeric species (Fig.  5, compare lanes 2 and 6) . This result is in excellent agreement with what would be predicted theoretically. If bAg-S and bAg(1-88) are present in equimolar amounts and the energetics of homodimer and heterodimer formation are equivalent, then a 1:2:1 ratio of bAg-S dimer to bAg-S/ bAg(1-88) heterodimer to bAg(1-88) dimer would be expected.
Packaging of bAg-L into HBV sAg particles requires a C-terminal Pro/Gly-rich domain. Of the aforementioned mutants which potently inhibited replication, several were unable to be packaged by HBV sAg. For instance, bAg was not found in sAg particles; however, when the Pro/Glyrich region spanning residues 146 to 214 was appended to it [bAg-L(A89-145)], packaging was restored (Table 1 and Fig.  4, lane F) . Similarly, a mutant with an even larger deletion, bAg-L(A69-146), was both packaged and competent in its ability to copackage bAg-S (Fig. 4, lane G) . Since the bAg-S version of the a.a. 89 to 146 deletion both lacked the isoprenylation site and was not packaged, the restoration of packaging seen with the addition of a.a. 146 to 214 to bAg(1-88) might solely reflect the requirement for this site. Another mutant, bAg-L(A101-202), however, indicated that the Pro/Gly-rich region was also needed, as this mutant contained the isoprenylation site but was still not packaged (Fig. 4 , lane E).
DISCUSSION
We have systematically deleted domains within the delta antigens in order to determine their contributions to the various functions of these proteins. This approach has the general limitation that it is possible, in deleting a given domain, to alter the structure of the protein so as to affect other regions. The loss of a function associated with the deletion of a domain could indicate that domain's direct role in the process or may only reflect the inactivation of a second critical domain. For this reason, deletion mutants which maintain function are far more informative, as it can be concluded, without ambiguity, that the structure responsible for that activity has remained intact. As a multifunctional protein, the delta antigen has proved to be particularly amenable to this approach, since it has been possible to abolish one function while preserving others. All of the major conclusions that arise from this work were obtained by using mutants which retain the function of interest. These conclusions can be summarized as follows. C-terminal Pro/Gly-rich region in its association with the hepadnaviral envelope proteins.
We deleted six of the seven amino acids which were previously identified as the core of the nuclear localization signal (33) , and as expected, these mutants displayed altered compartmentalization and were present in both the cytoplasm and the nucleus. Additional mutants demonstrate that the remaining amino acids of the NLS (a.a. 76 to 88) are not responsible for the residual access to the nucleus displayed by the a.a. 69 to 74 deletions. Surprisingly, and presumably as a consequence of this ability to reach the nucleus, bAg-S(A69-74) is fully competent in supporting replication, whereas BAg-L(A69-74) inhibits replication with wild-type efficiency and is packaged by HBV sAg. The small and large versions of BAg(A69-74) may be entering the nucleus by passive diffusion, as the nuclear pore is thought to be permeable to molecules smaller than 50 kDa (25) . Alterna Both the amino acid content and the predicted secondary structure of this domain are very different from the remainder of the antigen. More than 39% of the amino acids in this region are either proline or glycine, yet these residues constitute less than 12% of the amino-terminal portion. While residues 1 to 145 are extremely hydrophilic and predicted to include several a-helices, a.a. 146 to 214 are relatively nonpolar and are thought, because of the high content of proline and glycine, to be unable to assume this structure. These properties are consistent with a domain which is sequestered from the solvent, possibly by interaction with another protein. Although there is, as yet, no evidence that demonstrates the existence of an bAg-L/sAg protein interface, it is difficult to imagine how the large antigen could be so efficiently and selectively packaged without such an interaction taking place. We propose that the Pro/Gly-rich region interacts directly with the HBV sAg to facilitate packaging.
It should also be noted that all of the packaging-competent mutants presented contain the 19 C-terminal residues unique to bAg-L, underscoring the importance of this region. The relevance of these 19 a.a. to replication inhibition is less obvious, however. Previously, we had observed that when 84 heterologous amino acids were appended to the C terminus of bAg-S, or when an E. coli protein (MalE) was fused to its amino terminus, the inhibitory phenotype was elicited (20) . Neither (29) . The results presented here demonstrate that bAg-L (and the other trans-dominant inhibitor mutants) do not require the RNA-binding domain to access the RNP but can act via a coiled-coil interaction with bAg-S.
Ag-L could act through either a passive or active mechanism to poison the HDV RNP complex. In the passive model, any and all proteins which are themselves unable to support replication but can still interact with bAg-S would have access to the RNP and, by their mere presence, inhibit replication. This possibility is negated by the results obtained with bAg-S(A146-163), which does not support replication and does not inhibit replication but does have a functional coiled coil ( Table 1 ). The active model asserts that the inhibitor should not only interact with bAg-S but also must contain an activated function which interferes with the replication process.
What might this inhibitory function be? In addressing this question, we should make three points. First, there is no evidence to suggest that bAg-L directly prevents either the initiation, elongation, or maturation steps of HDV replication. All that is known is that, in the presence of bAg-L, fewer replicative products are observed. Thus, bAg-L could work through an indirect mechanism. Second, there is currently a gap in our understanding of how the HDV RNP, which is observed in the nucleus, can encounter and become packaged by the exclusively cytoplasmic hepadnaviral envelope proteins. Finally, there are a number of shuttle proteins, such as No38, nucleolin, and Noppl40, which show exclusively punctate nucleolar localization by immunofluorescence (2, 24) . Despite this staining pattern, these proteins are not restricted to the nucleus. More sensitive techniques have been used to demonstrate that the proteins can "piggyback" larger molecules associated with them in and out of the nucleus (2, 24) . All three of these proteins are phosphorylated and contain potentially complex nuclear localization signals with multiple NLS consensus sites. Similarly, bAg-L is a nucleolar phosphoprotein which has a bipartite NLS (5, 
33).
With these points in mind, we speculate that bAg-L can escort the HDV RNP from the nucleus to the cytoplasm. A nuclear export signal might reside within the first 68 a.a. of the antigen, which would be silenced in bAg-S but conformationally activated upon addition of the C-terminal 19 a.a. in bAg-L. bAg-L, through a coiled-coil interaction with the small antigen, would bind to the HDV RNP and move it to the cytoplasm, where the large antigen's isoprenylated Pro/Gly-rich region could interact with HBV sAg to induce packaging. This model also accounts for the transdominant inhibition simultaneously caused by bAg-L. As HDV RNP structures are removed from the nucleus, the nuclear pool of these species would be depleted, and as a consequence, replication would be reduced. Thus, a singlemolecule mechanism, nuclear export, can account for the superficially different phenotypes of packaging and replication inhibition. A direct investigation of the ability of bAg-L to exit the nucleus will be required to test the validity of this model.
